Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kunxian Capsule for Diabetic Nephropathy
NCT04981613Completed
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jul 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Kunxian Capsule in diabetic nephropathy (DN) (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: Changed levels of urinary protein at 48 weeks, The effective remission time of urinary protein at 48 weeks and 1 more. Started Jul 2021; status: completed.
02
Drugs
Kunxian Capsule
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT04981613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04981613.